Osteoporosis in the European Union: a compendium of country-specific reports

2013739 citationsReviewhybrid Open Access

Authors

the EU review panel of the IOF

A Svedbom

E Hernlund

M Ivergård · University of Cambridge

J. Compston · University of Oxford

Cyrus Cooper

J Stenmark · University of Sheffield

E. V. McCloskey · Stockholm School of Economics

B. Jönsson ·

Abstract

In spite of the high cost of osteoporosis, a substantial treatment gap and projected increase of the economic burden driven by aging populations, the use of pharmacological prevention of osteoporosis has decreased in recent years, suggesting that a change in healthcare policy concerning the disease is warranted.

Topics & Keywords

Bone health and osteoporosis research Bone Metabolism and Diseases Bone health and treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Archives of Osteoporosis

Volume 8, Issue 1-2, pp. 137-137

DOI: 10.1007/s11657-013-0137-0

Field-Weighted Citation Impact: 35.22